|
Volumn 20, Issue 4, 2014, Pages 344-346
|
Tumor Heterogeneity Confounds and Illuminates: A case for Darwinian tumor evolution
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
ESTROGEN RECEPTOR;
EVEROLIMUS;
EXEMESTANE;
FULVESTRANT;
MITOGEN ACTIVATED PROTEIN KINASE;
STEROID RECEPTOR;
TAMOXIFEN;
BONE MARROW BIOPSY;
BREAST CARCINOGENESIS;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CELL MIGRATION;
CIRCULATING TUMOR CELL;
ENDOMETRIUM CARCINOMA;
EPITHELIAL MESENCHYMAL TRANSITION;
GENE EXPRESSION;
HUMAN;
LIVER METASTASIS;
LUNG METASTASIS;
MOLECULARLY TARGETED THERAPY;
NOTE;
POINT MUTATION;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
TUMOR GROWTH;
BREAST NEOPLASMS;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
EPITHELIAL-MESENCHYMAL TRANSITION;
ESTROGEN RECEPTOR ALPHA;
EVOLUTION, MOLECULAR;
FEMALE;
GENETIC HETEROGENEITY;
HUMANS;
SELECTION, GENETIC;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
|
EID: 84898033361
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3518 Document Type: Note |
Times cited : (53)
|
References (15)
|